DoseMe Expands Global Footprint as Premier Hospitals and Cancer Centers across Australia Continue to Adopt Bayesian Dosing

    -DoseMe, a leading provider of model-informed precision dosing (MIPD) software, is pleased to announce the continued growth in Au...

April 17, 2024 | Wednesday | News
QIAGEN Introduces NeuMoDx HIV-1 Quant Assay in Thailand for Blood-Borne Virus Testing

QIAGEN has announced the approval of its NeuMoDx human immunodeficiency virus type 1 (HIV-1) assay for use in Thailand. This approval completes the suite o...

April 15, 2024 | Monday | News
Denovo Biopharma's Liafensine Shows Promise in Phase 2b Trial for Treatment-Resistant Depression

Denovo Biopharma LLC (Denovo), a pioneer in applying precision medicine to the development of innovative drugs, today announced positive results for its bi...

April 09, 2024 | Tuesday | News
OM1 and Medtronic Collaborate on Study Demonstrating Reduced Healthcare Resource Use with PROPEL Devices in Sinus Surgery

-OM1, the leading AI and insights-driven technology and data company specializing in personalized medicine, evidence generation, and real-world evidence, t...

April 09, 2024 | Tuesday | News
GE HealthCare Introduces Caption AI for Vscan Air SL Ultrasound System, Enhancing Cardiac Care Accessibility

GE HealthCare (Nasdaq: GEHC) announces a groundbreaking advancement in cardiac care with the launch of Caption AI artificial intelligence (AI)-driven softw...

April 04, 2024 | Thursday | News
Johnson & Johnson Expands Commitment to Advance Health Equity

Johnson & Johnson announced  that it is collaborating with more than 100 community-led health organizations supporting historically marginalized c...

April 04, 2024 | Thursday | News
dsm-firmenich and OMG Pharma Collaborate on CBD-Based Insomnia Drugs

Leveraging dsm-firmenich’s high quality GMP CBD active pharmaceutical ingredient (API) and leading-edge formulation capabilities, chiefly its bioavai...

April 03, 2024 | Wednesday | News
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

  Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company specializing in allosteric modulation-based drug development,...

April 03, 2024 | Wednesday | News
Key Proteo Advances Early Detection of Rare Genetic Disorders with FDA Submission of Newborn Screening Kit

Key Proteo, a pioneering proteomics diagnostics company specializing in the enhanced early detection of rare but treatable genetic disorders, today announc...

April 01, 2024 | Monday | News
Laborie Medical Technologies Corp. Invests in iO Urology's Revolutionary At-Home Uroflow Device for BPH Management

Leading diagnostic and therapeutic medical technology company Laborie Medical Technologies Corp. (Laborie) announced its investment in iO Urology, a vent...

April 01, 2024 | Monday | News
China Medical University Hospital (CMUH) Innovates iDREAM for Home Detection of Sleep Apnea

Snoring can be an alarming sign of obstructive sleep apnea syndrome (OSAS). Studies showed that 50% of individuals who snore may experience sleep apnea, wh...

April 01, 2024 | Monday | News
FDA Approves Roche's First Molecular Test for Malaria Screening in Blood Donors

The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria Malaria is a serious and potentially fatal paras...

March 27, 2024 | Wednesday | News
 GE HealthCare Secures FDA 510(k) Clearance for IONIC Health’s nCommand Lite System to Alleviate Radiology Staffing Shortages

  GE HealthCare (Nasdaq: GEHC) announces the U.S. FDA 510(k) Clearance of IONIC Health’s revolutionary nCommand Lite technology, aimed at mitig...

March 26, 2024 | Tuesday | News
Gilead Sciences Completes Acquisition of CymaBay, Strengthening Liver Disease Therapies

    “The acquisition of CymaBay brings us a potential best-in-disease therapy that could transform the treatment landscape for people wit...

March 25, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close